Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STING pathway agonism as a cancer therapeutic
Blake Flood, Emily F. Higgs, Shuyin Li, et al.
Immunological Reviews (2019) Vol. 290, Iss. 1, pp. 24-38
Open Access | Times Cited: 265

Showing 51-75 of 265 citing articles:

STING agonist cGAMP enhances anti-tumor activity of CAR-NK cells against pancreatic cancer
Yanyan Da, Yuxia Liu, Yuan Hu, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 55
Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness
Robby Barnestein, Loïck Galland, Laura Kalfeist, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 54
Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy
Huan Zheng, Beibei Guo, Xinyun Qiu, et al.
Bioactive Materials (2022) Vol. 16, pp. 1-11
Open Access | Times Cited: 45
Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems
Adam M. Weiss, Samir Hossainy, Stuart J. Rowan, et al.
Macromolecules (2022) Vol. 55, Iss. 16, pp. 6913-6937
Open Access | Times Cited: 45
Epigenetic state determines inflammatory sensing in neuroblastoma
Adam J. Wolpaw, Liron D. Grossmann, Jessica L. Dessau, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 6
Open Access | Times Cited: 40
Activation of Stimulation of Interferon Genes (STING) Signal and Cancer Immunotherapy
Ke-Wang Luo, Ning Li, Wei Ye, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4638-4638
Open Access | Times Cited: 40
UNC93B1 attenuates the cGAS–STING signaling pathway by targeting STING for autophagy–lysosome degradation
Huifang Zhu, Rongzhao Zhang, Yi Li, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 9, pp. 4490-4501
Closed Access | Times Cited: 39
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 33
Cancer vaccines in the clinic
Morgan E. Janes, Alexander P. Gottlieb, Kyong Soo Park, et al.
Bioengineering & Translational Medicine (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 32
Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy
Hao Yang, Zhong‐Hao Ji, Hengzong Zhou, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 31
A Booster for Radiofrequency Ablation: Advanced Adjuvant Therapy via In Situ Nanovaccine Synergized with Anti-programmed Death Ligand 1 Immunotherapy for Systemically Constraining Hepatocellular Carcinoma
Tian Zhou, Qitao Hu, Zhouyi Sun, et al.
ACS Nano (2023) Vol. 17, Iss. 19, pp. 19441-19458
Closed Access | Times Cited: 27
Synthetic enforcement of STING signaling in cancer cells appropriates the immune microenvironment for checkpoint inhibitor therapy
Larsen Vornholz, Sophie E. Isay, Zsuzsanna Kurgyis, et al.
Science Advances (2023) Vol. 9, Iss. 11
Open Access | Times Cited: 26
Sonodynamic amplification of cGAS-STING activation by cobalt-based nanoagonist against bone and metastatic tumor
Jie Lei, Weifeng Zhang, Liang Ma, et al.
Biomaterials (2023) Vol. 302, pp. 122295-122295
Closed Access | Times Cited: 24
Unlocking the promise of systemic STING agonist for cancer immunotherapy
Xiaoqi Sun, Xingwu Zhou, Yu L. Lei, et al.
Journal of Controlled Release (2023) Vol. 357, pp. 417-421
Open Access | Times Cited: 22
Mitophagy and cGAS–STING crosstalk in neuroinflammation
Xiaogang Zhou, Jing Wang, Lu Yu, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 8, pp. 3327-3361
Open Access | Times Cited: 12
Nanomaterial-mediated modulation of the cGAS-STING signaling pathway for enhanced cancer immunotherapy
Yaxin Wang, Yunmeng Liu, Jincheng Zhang, et al.
Acta Biomaterialia (2024) Vol. 176, pp. 51-76
Closed Access | Times Cited: 10
Tumor cell-directed STING agonist antibody-drug conjugates induce type III interferons and anti-tumor innate immune responses
Naniye Malli Cetinbas, Travis Monnell, Jahna Soomer-James, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
A next-generation STING agonist MSA-2: From mechanism to application
Junhan Yang, Zhenyu Luo, Jingyi Ma, et al.
Journal of Controlled Release (2024) Vol. 371, pp. 273-287
Closed Access | Times Cited: 8
Phototherapy: progress, challenges, and opportunities
Xi Yuan, Junliang Zhou, Lin Yuan, et al.
Science China Chemistry (2024)
Closed Access | Times Cited: 8
Platinum(IV)-Backboned Polymer Prodrug-Functionalized Manganese Oxide Nanoparticles for Enhanced Lung Cancer Chemoimmunotherapy via Amplifying Stimulator of Interferon Genes Activation
Li Liu, Shengxiang Fu, Haojie Gu, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Activating the cGAS-STING Pathway by Manganese-Based Nanoparticles Combined with Platinum-Based Nanoparticles for Enhanced Ovarian Cancer Immunotherapy
Xiangling Zhang, Dongsheng Tang, Haihua Xiao, et al.
ACS Nano (2025)
Closed Access | Times Cited: 1
Intrinsic STING of CD8 + T cells regulates self-metabolic reprogramming and memory to exert anti-tumor effects
Qiuli Xu, Xin Hua, Bingbing Li, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses
Xiaodong Jiang, Viswanathan Muthusamy, Olga Fedorova, et al.
The Journal of Experimental Medicine (2019) Vol. 216, Iss. 12, pp. 2854-2868
Open Access | Times Cited: 62
Metal-based nano-vaccines for cancer immunotherapy
Jiexin Li, He Ren, Yumiao Zhang
Coordination Chemistry Reviews (2021) Vol. 455, pp. 214345-214345
Closed Access | Times Cited: 54
Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides
Ilio Vitale, Takahiro Yamazaki, Erik Wennerberg, et al.
Trends in cancer (2021) Vol. 7, Iss. 6, pp. 557-572
Open Access | Times Cited: 53

Scroll to top